Vymada 200mg

Price range: $170.00 through $410.00

Tablet/s
Choose an option
Vymada 200mg
Add to cart
Buy Now
SKU: N/A Category:
Category Details
Active Ingredients Sacubitril 97 mg + Valsartan 103 mg per tablet (200 mg total)
Indication Chronic Heart Failure (NYHA Class II-IV)
US Brand Entresto (Novartis)
Manufacturer Novartis India Ltd. (Part of Novartis AG)
Packaging 7 tablets/strip
Strength Sacubitril 97 mg + Valsartan 103 mg
Delivery Time 6–15 days

🌟 Introduction to Vymada 200 mg (Sacubitril/Valsartan)

Vymada 200 mg by Novartis India is a dual-action therapy combining Sacubitril (neprilysin inhibitor) and Valsartan (ARB) to treat chronic heart failure. This innovative combo reduces strain on the heart by blocking harmful hormones (angiotensin II) and enhancing protective ones (natriuretic peptides). Clinical trials show it lowers hospitalization risk by 20% and cuts cardiovascular deaths by 16% compared to traditional therapies. Packaged in 7-tablet strips, Vymada offers a cost-effective alternative to Entresto, adhering to WHO-GMP standards.


🧪 Chemical Composition

Component Role
Sacubitril Neprilysin inhibitor (97 mg)
Valsartan Angiotensin II receptor blocker (103 mg)
Microcrystalline Cellulose Binder/Stabilizer
Magnesium Stearate Lubricant

🏭 Manufacturer Spotlight: Novartis India

Novartis India, a subsidiary of Swiss pharma giant Novartis AG, is a leader in cardiovascular and oncology therapies. Founded in 1996, it operates under WHO-GMP, USFDA, and EU-GMP standards, exporting to 50+ countries. Vymada reflects its commitment to cutting-edge, affordable care.


🌍 How to Buy Vymada in the US, Australia & UK

United States:

  • Prescription Required: Yes (FDA-approved Entresto costs 500–600/month).

  • Cost Savings:

    Source Price (28 tablets)
    US Brand (Entresto) 500–600
    Vymada (India) 50–100

Australia/UK:

  • Import Rules: ≤3 months’ supply for personal use. Submit a valid prescription (TGA/NHS).


💡 Dosage & Usage

Recommended Dosage:

  • Starting Dose: 49/51 mg twice daily (titrate to 97/103 mg).

  • Maintenance: 200 mg (Sacubitril/Valsartan) twice daily.

Usage Tips:
🌀 Take 1 hour before/2 hours after meals for optimal absorption.
🌀 Avoid potassium supplements (risk of hyperkalemia).


⚠️ Side Effects & Precautions

Common Effects (≤15% Users) Rare Risks (≤2% Users)
Dizziness Angioedema (facial swelling)
Hyperkalemia Kidney dysfunction

FDA Warning: Contraindicated in pregnancy (fetal toxicity) or with ACE inhibitors (FDA).


🔗 Internal Links to Indian Brands

  1. Valzaar: Valsartan by Torrent Pharma.

  2. Cardivas: Carvedilol for heart failure.

  3. Lasix: Furosemide for edema.

  4. Zyloric: Allopurinol for gout.


🩺 Expert Opinion: Dr. Arjun Patel

*“Vymada’s dual mechanism revolutionizes heart failure management. Novartis’ formulation matches Entresto’s efficacy but at 80% lower cost, making it a game-changer for patients needing long-term therapy.”*
— Dr. Arjun Patel, Cardiologist, Kokilaben Dhirubhai Ambani Hospital, Mumbai


📦 Storage Guide

Condition Requirement Icon
Temperature Below 30°C 🌡️
Moisture Keep in original strip 🛡️
Light Avoid exposure 🌑

📝 Prescription Requirements

  • US/UK/AU: Mandatory. Use platforms like Practo for online consultations.


📊 Price Comparison: India vs. Global

Country Price (28 tablets) Savings vs. US
India ₹3,000–₹5,000 (40–67) 80–85%
USA 500–600
UK £400–£500 75–80%
Australia AUD 600–AUD 800 70–75%

Authoritative Resources:


🌟 Pro Tip: Pair Vymada with low-sodium diets and daily weight monitoring to manage heart failure effectively!

Additional Information

Active

Sacubitril/Valsartan

Tablet/s

28, 56, 84

Top